A microRNA expression signature in infant t(4;11) MLL-AF4+ BCP-ALL uncovers novel therapeutic targets

Camille Malouf(MRC Centre for Regenerative Medicine), Katrin Ottersbach(MRC Centre for Regenerative Medicine)
bioRxiv (Cold Spring Harbor Laboratory)
January 15, 2023
10.1101/2023.01.12.523775
Cited by 0

Related Papers

Endothelial-to-haematopoietic transition: an update on the process of making blood
|Biochemical Society Transactions|2019|120
Molecular processes involved in B cell acute lymphoblastic leukaemia
|Cellular and Molecular Life Sciences|2017|85
miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia
|Blood|2021|33
Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly(I:C), but not to a single maternal immune activation
|Experimental Hematology|2019|7